E-Z-EM today announced financial results for the fiscal 2007 Q2 with net sales from continuing operations at $34.2 million, up one percent compared with $33.8 million for the quarter ended December 3, 2005. The company attributed the increase in net sales to continued growth in CT imaging product sales, price increases and favorable foreign currency exchange rates, which were offset by declines in contract manufacturing, X-ray fluoroscopy and RSDL skin decontamination product sales. Gross profit for Q2 improved to $15.3 million from $15.1 million for the prior-year quarter, and as a percentage of net sales was 45 percent for both quarters. Increased costs for finished goods and raw materials were offset by decreased provision for inventory reserves and price increases. Operating expenses for the fiscal 2007 second quarter were $13.0 million, up three percent from $12.6 million for the comparable prior-year quarter.